EMA/EBE Fifth Annual Regulatory Conference on ATMPs
The fifth annual regulatory conference organised by European Biopharmaceutical Enterprises (EBE), with the collaboration of the European Medicines Agency (EMA) was held in London on December 16.
This one-day conference discussed initiatives to improve advanced therapy medicinal products (ATMPs) access to patients, specific requirements for gene-therapy medicinal products, meeting specific standards for development and commercialisation of ATMPs in addition to listening to the stakeholders of innovative medicines.
This informative forum brought together speakers and panellists from a broad range of public and private stakeholders, including patients, academia, regulators, investors and industry. The slides for this conference are now available on the EMA website via this link.